BMO Capital analyst Ambrish Srivastava maintains Broadcom (NASDAQ:AVGO) with a Outperform and lowers the price target from $675 to $650.
Gilead Sciences Shares Trade Higher After Bullish Analyst Upgrades Stock
Shares of Gilead Sciences, Inc. (NASDAQ: GILD) are trading higher into Friday’s trading session after Bank of America Securities upgraded the stock, highlighting an underappreciated growth potential in its core HIV business and emerging hem